14 October 2026 Date of AGM and Closing Date for Director Nominations Argent BioPharma Limited (ASX: RGT) advises, in accordance with ASX Listing Rule 3.13.1, that the Company’s Annual General Meeting is scheduled to be held on Friday, 20 November 2026. The closing date for receipt of nominations...
Date of AGM and Closing Date for Director Nominations
Filed with ASX · · 1 page · English
Summary by 6ix AI
Argent Biopharma Ltd has announced the date for its Annual General Meeting and the closing date for director nominations. The AGM is scheduled for a specific date in November, while nominations for directors must be submitted by a specified time in October. This filing serves to inform shareholders about important upcoming corporate governance events.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Argent Biopharma
- Strategic Focus on Immune Modulation and Longevity
- Application for quotation of securities - RGT
- Execution of Loan Facility Agreement
- Argent Signs NLC Licence to Expand Antiviral Portfolio
- Proposed issue of securities - RGT
Later from Argent Biopharma
- Notice of Annual General Meeting/Proxy Form
- Quarterly Activities/Appendix 4C Cash Flow Report
- RGT Executes Global Licence for Non-Core Cannabis Genetics
- Becoming a substantial holder
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma